tirzepatide anesthesia guidelines How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like One-Week GLP-1 Agonist Hold Not

Letko M, Seifert SN, Olival KJ, Plowright RK, Munster VJ

Very professional he has a great team working with him

Surma et al., 2011)

Its not enough to just take these medications you want to engage in healthy nutritional behaviors and minimize certain side effects that can come from using them. About 25% of a patients weight loss on GLP-1s is muscle mass or lean mass

We also explored several other known regulators of PGC1 activity that are altered in response to 5FU treatment in HCT116, including NRF2, reactive oxygen species and PPAR, but none of these prevented PGC1-driven increases in mitochondrial mass

Track fat loss, cm reduction, and muscle gain